3

FORM 3 SUBMISSION

Company: HERON THERAPEUTICS, INC. /DE/
Filed: April 24, 2017
Period of Report: April 24, 2017
Accession Number: 0001209191-17-028036

View Document ↗ View on SEC.gov ↗